Skip to content
Screener

Harmony Biosciences Holdings, Inc. HRMY Business Segments — Investment Income Nonoperating

Similar metrics at other companies

Coda Octopus Group, Inc. logo
CODACorporate — Investment Income Nonoperating
$5.16K-83.9%
Brown & Brown logo
BRORetail — Investment Income Nonoperating
$7M+133%
Brown & Brown logo
BROSpecialty Distribution — Investment Income Nonoperating
$7M0.0%
Coda Octopus Group, Inc. logo
CODADefense Engineering Services Business — Investment Income Nonoperating
$32.21K+24.1%
Coda Octopus Group, Inc. logo
CODAMarine Technology Business Products — Investment Income Nonoperating
$133.66K+54.8%
Coda Octopus Group, Inc. logo
CODAAcoustic Sensors And Materials Business — Investment Income Nonoperating
$891-30.9%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$2.26B+13.1%
Enterprise value$1.83B+12.9%
P/E15.5×+4.5×
P/S2.5×-0.1×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNonoperating.

The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:16 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056720
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
General and administrative (d)20,39817,878
Depreciation and amortization5,9685,968
Stock-based compensation10,30812,450
Interest expense3,2343,836
Interest income(5,757)(5,044)
Income tax expense7,19911,617
Other segment items (e)32,127276
Consolidated net income$32,488$45,560

Item 1. Financial Statements

FAQ

What is Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating?
Harmony Biosciences Holdings, Inc. (HRMY) reported business segments — investment income nonoperating of $5.76M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating changed year-over-year?
Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating increased by 14.1% year-over-year, from $5.04M to $5.76M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating?
Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating has grown at a 91.4% compound annual growth rate (CAGR), from $3.13M to $21.92M.
What does business segments — investment income nonoperating mean?
This captures the income generated from cash reserves, marketable securities, or other financial investments held by the company. It reflects the efficiency of the company's treasury management and the returns on its non-operating liquid assets.

Ask your AI about Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude